1
![Interleukin Genetics]()
![Interleukin Genetics]()
![Interleukin Genetics]()
Interleukin Genetics
Leadership team
Kenneth S. Kornman (Founder)
Products/ Services
Biotechnology, Genetics, Health Care, Medical
Number of Employees
0 - 50
Headquarters
Waltham, Massachusetts, United States
Established
1997
Company Registration
SEC CIK number: 0001037649
Traded as
OTCQB:ILIU
Overview
Location
Summary
Interleukin Genetics is a biotechnology research and development company focused on developing personalized health assessment tools based on the unique genetic background of each patient.
History
The company was founded in 1995 with a mission to use genomics and genetic technology to develop personalized health assessment tools. Since then, Interleukin Genetics has become a global leader in developing and marketing genomic-based products as well as leading-edge diagnostic tests to assess risk for serious health conditions.
Mission
At Interleukin Genetics, our mission is to develop and deliver novel genomic-based products to improve health and wellness, address unmet healthcare needs and empower individuals to make informed decisions.
Vision
We envision a world where individuals can access their individualized health risk profile, so that they can take action to improve their quality of life.
Key Team
Kenneth S. Kornman (Founder)
Recognition and Awards
Interleukin Genetics has been the recipient of multiple awards for innovation, including the Innovations Award for Life Sciences from the Connecticut Technology Council, and the National Technology Award from the Global Technology Symposium.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Kenneth S. Kornman (Founder)
Products/ Services
Biotechnology, Genetics, Health Care, Medical
Number of Employees
0 - 50
Headquarters
Waltham, Massachusetts, United States
Established
1997
Company Registration
SEC CIK number: 0001037649
Traded as
OTCQB:ILIU